Japer Therapeutics, Inc. Warrants
JSPRWStock
$0.01
Market Cap—
P/E—
Div yield—
Beta2.89
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-96.32%
Price vs S&P 500 (4W)2.90%
VGM Score30.62
Industry Peers — Biological Products(180)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
JSPRWJaper Therapeutics, Inc. Warrants | — | — | D | $0.01 |
| AMGNAmgen Inc | C | C | C | $371.58 |
| GILDGilead Sciences Inc | C | B | C | $136.30 |
| ARGXargenx SE American Depositary Shares | D | A | B | $857.97 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $179.18 |
| BIIBBiogen Inc. Common Stock | B | D | B | $208.92 |
| BNTXBioNTech SE American Depositary Share | C | C | C | $91.56 |
| MRNAModerna, Inc. Common Stock | D | B | B | $63.15 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $171.55 |
| EXELExelixis Inc | C | B | B | $55.68 |
| TECHBio-Techne Corp. | D | C | B | $71.77 |
About
Jasper Therapeutics is a clinical-stage biotech company developing safer conditioning agents and advanced stem cell engineering technologies to expand the use of hematopoietic stem cell transplantation and ex vivo gene therapy. The company's platform aims to enable broader patient access to stem cell-based treatments by improving efficacy and safety outcomes.